You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 273 Phase i study of LioCyx-M, autologous hepatitis B virus (HBV)-specific T cell receptor (TCR) T-cells, in recurrent HBV-related hepatocellular carcinoma (HCC) post-liver transplantation

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
273 Phase i study of LioCyx-M, autologous hepatitis B virus (HBV)-specific T cell receptor (TCR) T-cells, in recurrent HBV-related hepatocellular carcinoma (HCC) post-liver transplantation

 

Online download statistics by month:

Online download statistics by month: November 2020 to August 2024

AbstractFullPdf
Nov 2020188027
Dec 202050016
Jan 202118013
Feb 202122010
Mar 202148014
Apr 202138011
May 2021303
Jun 2021004
Jul 2021006
Aug 2021109
Sep 2021009
Oct 202138020
Nov 202166017
Dec 20212608
Jan 20223602
Feb 20224006
Mar 202254010
Apr 20224403
May 20223001
Jun 20223005
Jul 20223402
Aug 20222004
Sep 20224805
Oct 20223400
Nov 20224406
Dec 20222401
Jan 20234609
Feb 20232803
Mar 20234404
Apr 20231804
May 20231805
Jun 20232202
Jul 20232004
Aug 20235409
Sep 20234402
Oct 20235809
Nov 20234605
Dec 20233604
Jan 20241603
Feb 20241601
Mar 20243005
Apr 20243803
May 20244804
Jun 20242901
Jul 20244403
Aug 20244204
Total16330296